Company Milestone Scientific Inc.
Equities
MLSS
US59935P2092
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.65 USD | -6.61% | +16.07% | -5.78% |
Business Summary
Number of employees: 17
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Dental
99.3
%
| 9 | 99.4 % | 10 | 99.3 % | +11.52% |
Medical
0.7
%
| 0 | 0.6 % | 0 | 0.7 % | +25.12% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
54.6
%
| 3 | 37.4 % | 5 | 54.6 % | +62.98% |
Rest of World
42.7
%
| 5 | 55.5 % | 4 | 42.7 % | -14.13% |
China
2.7
%
| 1 | 7.2 % | 0 | 2.7 % | -57.14% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jan Haverhals
CEO | Chief Executive Officer | 61 | 01/20/01 |
Mark Hochman
CTO | Chief Tech/Sci/R&D Officer | 63 | 01/99/01 |
Leonard Osser
BRD | Director/Board Member | 76 | 01/91/01 |
Andy Molnar
SAM | Sales & Marketing | 62 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Leonard Osser
BRD | Director/Board Member | 76 | 01/91/01 |
Director/Board Member | 63 | 14/14/14 | |
Neal Goldman
CHM | Chairman | 80 | 03/19/03 |
Director/Board Member | 54 | 27/22/27 | |
Michael McGeehan
BRD | Director/Board Member | 58 | 06/17/06 |
Jan Haverhals
CEO | Chief Executive Officer | 61 | 01/20/01 |
Didier Demesmin
BRD | Director/Board Member | - | 06/23/06 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 76,635,449 | 65,022,890 ( 84.85 %) | 33,333 ( 0.0435 %) | 84.85 % |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.78% | 49.79M | |
+7.84% | 218B | |
+7.35% | 184B | |
+13.04% | 135B | |
-1.33% | 62.38B | |
+11.80% | 51.37B | |
+4.81% | 50.9B | |
+0.30% | 40.87B | |
+2.78% | 36.28B | |
+26.14% | 31.88B |
- Stock Market
- Equities
- MLSS Stock
- Company Milestone Scientific Inc.